Maximizing Safety in the Conduct of Alzheimer’s Disease Fluid Biomarker Research in the Era of COVID-19

The coronavirus disease 2019 (COVID-19) pandemic led to an abrupt halt of many Alzheimer’s disease (AD) research studies at sites spanning the world. This is especially true for studies requiring in-person contact, such as studies collecting biofluids. Since COVID-19 is likely to remain a threat for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Alzheimers Dis
Main Authors: Schindler, Suzanne E., Jicha, Gregory A., Nelson, Peter T., Keene, C. Dirk, Blennow, Kaj, Molinuevo, José Luis, Masters, Colin L., Hansson, Oskar, Teunissen, Charlotte E., Galasko, Douglas, Shaw, Leslie M., Levey, Allan I., Silverberg, Nina
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7995336/
https://ncbi.nlm.nih.gov/pubmed/32568212
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200684
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados